98%
921
2 minutes
20
Background: Hashimoto thyroiditis (HT) combined with papillary thyroid cancer (PTC) is more common in clinical practice, maybe posing a serious threat to the health of patients. It is uncertain whether HT is a risk factor or protective factor for PTC. The aim of the study was to retrospectively explore the effect of HT on the biological behavior of PTC.
Methods: A total of 200 patients were included in the study. Among them, 100 patients with PTC without HT were in the control group (PTC group), and 100 cases diagnosed as PTC with HT were in the experimental group (HT + PTC group). The following data were counted and analyzed, respectively: (1) the basic clinicopathologic characteristics of patients; (2) postoperative thyroid function indicators; (3) blood biochemical indicators; (4) liver function indicators; and (5) histopathological report.
Results: Compared with the PTC group, women were predominant in the PTC + HT group ( < .05). In addition, the central lymph node metastasis rate, the number of cervical lymph node metastases, and the lateral cervical lymph node metastasis rate were significantly decreased ( < .05). Thyroid peroxidase antibody (TPOAb), thyroid-stimulating hormone (TSH), and thyroglobulin antibody (TGAb) of the thyroid function index were significantly increased, while the thyroglobulin (TG) value was significantly decreased ( < .05). The alkaline phosphatase (ALP) level of the liver function index was significantly decreased, while the lactate dehydrogenase (LDH) level was significantly increased ( < .05). In the pathological examination, a large number of mononuclear cells infiltrated in the lymphocyte follicular stroma. In an ultrasound examination, the boundary definition rate is lower.
Conclusion: Women may be more susceptible to PTC or PTC and HT than men. Patients under 55 years old accounted for a larger proportion in PTC + HT than PTC. Hashimoto thyroiditis may play an inhibitory role in the occurrence of PTC, and the presence of HT is a protective factor for PTC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489922 | PMC |
http://dx.doi.org/10.1177/11795549241287085 | DOI Listing |
Virchows Arch
September 2025
Ningbo Clinical Pathology Diagnosis Center, #685 Huancheng North Road, Ningbo, Zhejiang, 315000, China.
The spindle cell variant of papillary thyroid carcinoma (PTC) is exceptionally rare and poses significant diagnostic challenges due to its morphological overlap with other spindle cell lesions of the thyroid. We report a novel case of spindle cell variant PTC in a 66-year-old woman presenting with a TI-RADS 4 thyroid nodule, initially classified as Bethesda III on fine-needle aspiration. Histopathological examination revealed a biphasic tumor composed predominantly of bland spindle cells arranged in solid sheets and fascicles, admixed with entrapped thyroid follicles.
View Article and Find Full Text PDFCureus
August 2025
Faculty of Medicine, University of Costa Rica, San José, CRI.
Struma ovarii (SO) is a rare form of ovarian teratoma predominantly composed of thyroid tissue. While most cases follow a benign course, some may exhibit malignant transformation or extra-ovarian spread. We present the case of a 43-year-old woman with a history of SO previously treated with right oophorectomy and systemic chemotherapy, along with a separate diagnosis of papillary thyroid carcinoma managed with total thyroidectomy and radioactive iodine ablation.
View Article and Find Full Text PDFBiosens Bioelectron
September 2025
College of Chemistry, Jilin Province Research Center for Engineering and Technology of Spectral Analytical Instruments, Jilin University, Qianjin Street 2699, Changchun, 130012, China. Electronic address:
Papillary thyroid carcinoma (PTC) is the most prevalent form of thyroid cancer with a high incidence among endocrine malignancies. It tends to metastasize early in lymph nodes and differs markedly from other subtypes in biological behavior, clinical management, and prognosis. Therefore, accurately distinguishing PTC from other pathological subtypes is crucial for guiding diagnosis and treatment decisions.
View Article and Find Full Text PDFInt J Surg
September 2025
Department of Thyroid Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Cureus
August 2025
Department of Otolaryngology - Head and Neck Surgery, China Medical University Hospital, Taichung, TWN.
Synchronous malignancies involving the oropharynx and thyroid gland are rare. We report the case of a 52-year-old female diagnosed with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) with a concurrent, clinically occult papillary thyroid carcinoma (PTC). The patient initially presented with HPV-associated OPSCC and concerns for cervical lymphadenopathy, presumed to be linked to regional metastasis from the oropharyngeal primary.
View Article and Find Full Text PDF